During the past decade, Southeast Clinical Research, LLC conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 10 clinical trials were completed, i.e. on average, 500% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southeast Clinical Research, LLC" #1 sponsor was "AstraZeneca" with 3 trials, followed by "Pfizer" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Biota Scientific Management Pty Ltd" with 1 trials sponsored and "Bristol-Myers Squibb" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southeast Clinical Research, LLC" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator and "Nektar Therapeutics" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Southeast Clinical Research, LLC" are "Low Back Pain" (3 trials), "Type 2 Diabetes" (2 trials), "Chronic Obstructive Pulmonary Disease" (1 trials), "Clostridium Difficile Infection" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Southeast Clinical Research, LLC" in a lesser frequency.

Most popular intervention types in "Southeast Clinical Research, LLC" are "Drug" (10 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Dapagliflozin" (2 trials), "Placebo matching with Saxagliptin" (2 trials), "Saxagliptin" (2 trials) and "40 mg Laninamivir Octanoate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southeast Clinical Research, LLC" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Southeast Clinical Research, LLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Southeast Clinical Research, LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Southeast Clinical Research, LLC, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".